Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
Marina Vogel-González, Marc Talló-Parra, Víctor Herrera-Fernández, Gemma Pérez‐Vilaró, Miguel Chillón, Xavier Nogués +10 more
Nutrients
Abstract
Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency.
Concepts
MicronutrientBiomarkerZincImmunologyImmune systemPathogenDiseaseCoronavirus disease 2019 (COVID-19)